MedPath

Validation of Pulsewave Blood Pressure Monitor in Hypertensive and Normotensive Pregnant and Postpartum Women

Withdrawn
Conditions
Hypertension
Registration Number
NCT02823873
Lead Sponsor
University of Arkansas
Brief Summary

The purpose of this study is to test the accuracy of the Pulsewave wrist blood pressure cuff in pregnant and postpartum women who have either normal blood pressure or high blood pressure.

Detailed Description

The study will include a series of nine blood pressure measurements. The measurements will alternate between a gold standard auscultatory blood pressure measurement and the Pulsewave monitor.

A trained clinician will be used for gold standard measurements using an appropriately sized cuff around the upper arm, a sphygmomanometer, and a stethoscope. Systolic blood pressure is defined by the first Korotkoff sound; diastolic blood pressure is defined by the fifth Korotkoff sound.

Measurements by the Pulsewave monitor will be performed using a proprietary oscillometric wrist cuff automated by a computer tablet and software made by CloudDx Inc.

Women will be seated for 5 to 10 minutes before the first blood pressure measurement. During this time, 4 circumference measurements will be taken of the arm and wrist.

1. The armpit will be measured as proximally as possible.

2. The mid upper arm will be recorded by measuring at the halfway point between the acromion and the olecranon process.

3. The distal upper arm measurement will be taken approximately 2 cm proximal to the antecubital crease.

4. The wrist will be measured approximately 2 cm proximal to the wrist flexion crease.

The first two blood pressure measurements will be used as a way to orient the subject to each device and the methods so that they are comfortable with the cuff and the process. The seven subsequent measurements will be used for analysis. There will be a 30 second to 60 second period between blood pressure measurements.

Recruitment & Eligibility

Status
WITHDRAWN
Sex
Female
Target Recruitment
Not specified
Inclusion Criteria
  • Pregnant or admitted to the postpartum unit
  • Normotensive women - No diagnosis of hypertension
  • Hypertensive women - Diagnosis of hypertensive disorder of pregnancy
Exclusion Criteria
  • Women in active labor
  • Women < 18 years of age
  • Non-english speakers

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Proportion of measurements by Pulsewave cuff that are within 5 mmHg of standard clinical measurementsImmediately after blood pressure measurement

Test measurement will be compared to standard measurements made at the same time.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University of Arkansas for Medical Sciences

🇺🇸

Little Rock, Arkansas, United States

University of Arkansas for Medical Sciences
🇺🇸Little Rock, Arkansas, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.